Asma M. Aman

3.8k citations
45 papers · 1.5k indexed · h-index 20
  • Biomaterials top 10%
    • Nanoparticle-Based Drug Delivery 4
  • Genetics top 10%
    • Glioma Diagnosis and Treatment 12
    • Epigenetics and DNA Methylation 6
    • Protein Degradation and Inhibitors 6
    • Metabolomics and Mass Spectrometry Studies 5
    • Ubiquitin and proteasome pathways 5
    • Histone Deacetylase Inhibitors Research 5
  • Physiology top 10%
  • Oncology top 10%
    • Mass Spectrometry Techniques and Applications 5

Asma M. Aman

42 papers receiving 1.5k citations

Peers

Asma M. Aman
Comparison fields: 5 of 110
  • Biomaterials 156
  • Genetics 124
  • Molecular Biology 693
  • Physiology 234
  • Oncology 238
Replace Ivana Campia with:
Ivana Campia Italy
John L. Stebbins United States
Yangbo Feng United States
Anna Laurenzana Italy
Xiaohong Shu China
Antonio Pezone Italy
Giovanni Galasso Italy
Bruno Perillo Italy
Loretta Lazzarato Italy
Marzia Di Donato Italy
Asma M. Aman relative to Ivana Campia Italy Ivana Campia's profile →
Citations per field
00.5×1.5×2.5×
Ivana Campia · 1×
Citations per year

Countries citing papers authored by Asma M. Aman

Since Specialization
Citations

This map shows the geographic impact of Asma M. Aman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asma M. Aman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asma M. Aman more than expected).

Fields of papers citing papers by Asma M. Aman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asma M. Aman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asma M. Aman. The network helps show where Asma M. Aman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Asma M. Aman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Asma M. Aman Line = papers co-authored together Asma M. Aman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20252
3 20243
4 20247
5 20243
6 20232
7 20232
8 202210
9 20227
10 202113
11 202116
12 202124
13 202015
14 201938
15 201886
16 201736
17 2016169
18 201614
19 201429
20 201283

About Asma M. Aman

Asma M. Aman is a scholar working on Genetics, Molecular Biology and Oncology, having authored 45 papers that have together received 1.5k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (12 papers), Epigenetics and DNA Methylation (6 papers), Protein Degradation and Inhibitors (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers), Mass Spectrometry Techniques and Applications (5 papers), Ubiquitin and proteasome pathways (5 papers), Histone Deacetylase Inhibitors Research (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). The work is most often cited by research in Biomaterials (156 citations), Genetics (124 citations) and Molecular Biology (693 citations). Asma M. Aman has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Rima Al‐awar, Samuel Weiss, Xianqi Kong, H. Artee Luchman, Julie Paquette, Aaron D. Schimmer, Mounia Azzi, Céline Morissette, Patrick Tremblay and Diane Lacombe. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026